Published in
Royal Society of Chemistry, Organic and Biomolecular Chemistry, 48(15), p. 10245-10255
DOI: 10.1039/c7ob00910k
Links
Tools
New active leads for tuberculosis booster drugs by structure-based drug discovery
Journal article published in 2017 by
Natalie J. Tatum,
John W. Liebeschuetz,
Jason C. Cole,
Rosangela Frita 
,
Adrien Herledan,
Alain R. Baulard ,
Nicolas Willand,
Ehmke Pohl
,
Adrien Herledan,
Alain R. Baulard ,
Nicolas Willand,
Ehmke Pohl
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Three new chemical scaffolds for the inhibition of the transcriptional regulator EthR from M. tuberculosis have been identified and verified by biophysical and biological assays.